Kinnevik
Kinnevik is a Swedish investment company that owns and actively supports a portfolio of growth businesses, mainly through equity investments in private and listed companies. Its portfolio has historically been concentrated in digital consumer, software, healthcare, and financial services businesses across Europe, the United States, and selected other markets.
Fiscal year 2025 · change from previous year
Development 2021–2025
Business
Share of revenueEquity stakes in private and public companies held for long-term value creation.
Strategic, governance, and operational support provided to portfolio companies.
Customers
Kinnevik does not sell products to end consumers; its direct counterparties are portfolio companies, founders, and co-investors. It allocates capital to businesses it believes can scale in large consumer and digital markets, while also engaging with management teams on strategy, governance, and performance. Its economic exposure is therefore tied to the operating results and valuation outcomes of the companies it owns.
Businesses receiving capital, governance support, and strategic input from Kinnevik.
Entrepreneurs partnering with Kinnevik for scale-up capital and active ownership.
Partners in funding rounds, divestments, and other portfolio transactions.
Investors buying Kinnevik shares for diversified exposure to its portfolio.
Strategy
Kinnevik’s strategy is to back challenger businesses with disruptive technology and support them as an active owner over long time horizons. It emphasizes disciplined capital allocation, portfolio construction, and governance across its holdings rather than operating a traditional product business.
Kinnevik seeks to create value through governance, strategic support, and capital allocation.
Diversification reduces dependence on any single company or industry outcome.
The model depends on identifying companies that can scale and compound value over time.
Geography
Kinnevik is headquartered in Sweden and is listed on Nasdaq Stockholm. Its investment activity is concentrated in Europe, especially the Nordics, with additional exposure to the United States and selected other markets through its portfolio companies.
Risks
Kinnevik’s main risks come from portfolio valuation changes, liquidity and financing needs, foreign exchange exposure, and interest rate sensitivity. Because its value is concentrated in equity investments, performance depends heavily on the operating progress and funding environment of portfolio companies, as well as market sentiment toward growth assets.
- Portfolio valuation riskImpact: HighLikelihood: Medium
Most of Kinnevik's value is tied to fair-valued investments whose prices can move sharply.
Exposure: Unlisted and listed equity holdings
- Liquidity and financing riskImpact: HighLikelihood: Low
The company may need cash for follow-on investments, commitments, or debt refinancing.
Exposure: Investment activity and balance sheet liquidity
- Interest rate riskImpact: MediumLikelihood: Low
Higher rates can raise financing costs and pressure growth-company valuations.
Exposure: Debt and valuation multiples
- Foreign exchange riskImpact: Medium
Portfolio companies operate in multiple currencies while reporting is in SEK.
Exposure: Cross-border investments and translations
Accounting
Judgemental itemsMost portfolio holdings are valued using models and assumptions rather than quoted prices.
Impact: Can materially change profit, equity, and NAV
Unobservable assumptions such as multiples, growth, and discount rates affect estimates.
Impact: High sensitivity to market conditions and company-specific performance
Non-cash distributions can affect comparability between periods.
Impact: May create volatility in reported investment income and equity
Similar listed companies
Publicly listed companies with a comparable business focus.
Healthier Choices Management Corp.
HCMC · Tobacco Products
Hong Yuan Holding Group
HGYN · Plastic Materials, Synth Resins & Nonvulcan Elastomers
HONG YUAN HOLDING GROUP is a U.S.-listed company in the plastics and synthetic resins value chain.
Valuence Merger Corp. I
VMCUF · Blank Checks
Valuence Merger Corp.
American Exceptionalism Acquisition Corp. A
AEXA · Blank Checks
American Exceptionalism Acquisition Corp.
Artificial Intelligence Technology Solutions Inc.
AITX · Services-Prepackaged Software
Amgen Inc
AMGN · Biological Products, (No Diagnostic Substances)
Last updated: 24/09/2026